Co-Diagnostics, Inc. Increase (Decrease) in Contract with Customer, Liability
Co-Diagnostics, Inc. (CODX) reported Increase (Decrease) in Contract with Customer, Liability of $13.84 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInContractWithCustomerLiability · last filed 2026-08-13
- Co-Diagnostics, Inc. increase (decrease) in contract with customer, liability for the quarter ending 2026-06-30 was $28.04K.
- Co-Diagnostics, Inc. increase (decrease) in contract with customer, liability for the quarter ending 2026-03-31 was -$14.20K.
- Co-Diagnostics, Inc. increase (decrease) in contract with customer, liability for the quarter ending 2025-12-31 was -$30.76K.
- Co-Diagnostics, Inc. increase (decrease) in contract with customer, liability for the quarter ending 2025-09-30 was -$300.00.
- Co-Diagnostics, Inc. increase (decrease) in contract with customer, liability for fiscal 2025 was -$26.06K.
- Co-Diagnostics, Inc. increase (decrease) in contract with customer, liability for fiscal 2024 was -$321.59K, a 188.73% decline from fiscal 2023.
- Co-Diagnostics, Inc. increase (decrease) in contract with customer, liability for fiscal 2023 was $362.45K.
- Co-Diagnostics, Inc. increase (decrease) in contract with customer, liability for fiscal 2022 was -$150.00K.
| Period end | Increase (Decrease) in Contract with Customer, Liability 3 month | Increase (Decrease) in Contract with Customer, Liability 6 month | Increase (Decrease) in Contract with Customer, Liability 9 month | Increase (Decrease) in Contract with Customer, Liability 12 month |
|---|---|---|---|---|
| 2026-06-30 | $28.04K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $13.84K 10-Q · filed 2026-08-13 | -$16.91K derived: sum of 3 quarters · filed 2026-08-13 | -$17.21K derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | -$14.20K 10-Q · filed 2026-05-14 | -$44.96K derived: sum of 2 quarters · filed 2026-05-14 | -$45.26K derived: sum of 3 quarters · filed 2026-05-14 | |
| 2025-12-31 | -$30.76K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$31.06K derived: sum of 2 quarters · filed 2026-03-31 | -$26.06K 10-K · filed 2026-03-31 | |
| 2025-09-30 | -$300.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $4.70K 10-Q · filed 2025-11-13 | ||
| 2025-06-30 | $5.00K 10-Q · filed 2026-08-13 | |||
| 2024-12-31 | -$19.62K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$180.07K derived: sum of 2 quarters · filed 2026-03-31 | -$265.62K derived: sum of 3 quarters · filed 2026-03-31 | -$321.59K 10-K · filed 2026-03-31 |
| 2024-09-30 | -$160.45K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$246.00K derived: sum of 2 quarters · filed 2025-11-13 | -$301.97K 10-Q · filed 2025-11-13 | -$289.02K derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | -$85.55K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$141.52K 10-Q · filed 2025-08-14 | -$128.57K derived: sum of 3 quarters · filed 2025-08-14 | -$37.07K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | -$55.97K 10-Q · filed 2025-05-08 | -$43.02K derived: sum of 2 quarters · filed 2025-05-08 | $48.48K derived: sum of 3 quarters · filed 2025-05-08 | $288.36K derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $12.95K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $104.45K derived: sum of 2 quarters · filed 2025-03-27 | $344.33K derived: sum of 3 quarters · filed 2025-03-27 | $362.45K 10-K · filed 2025-03-27 |
| 2023-09-30 | $91.50K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $331.38K derived: sum of 2 quarters · filed 2024-11-07 | $349.50K 10-Q · filed 2024-11-07 | $349.50K derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | $239.88K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $258.00K 10-Q · filed 2024-08-08 | $258.00K derived: sum of 3 quarters · filed 2024-08-08 | $258.00K derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $18.12K 10-Q · filed 2024-05-09 | $18.12K derived: sum of 2 quarters · filed 2024-05-09 | $18.12K derived: sum of 3 quarters · filed 2024-05-09 | $18.12K derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | $0.00 derived: sum of 2 quarters · filed 2024-03-14 | $0.00 derived: sum of 3 quarters · filed 2024-03-14 | -$150.00K 10-K · filed 2024-03-14 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $0.00 derived: sum of 2 quarters · filed 2023-11-09 | -$150.00K 10-Q · filed 2023-11-09 | -$189.56K derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$150.00K 10-Q · filed 2023-08-10 | -$189.56K derived: sum of 3 quarters · filed 2023-08-10 | -$163.13K derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | -$150.00K 10-Q · filed 2023-05-11 | -$189.56K derived: sum of 2 quarters · filed 2023-05-11 | -$163.13K derived: sum of 3 quarters · filed 2023-05-11 | -$158.79K derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | -$39.56K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | -$13.13K derived: sum of 2 quarters · filed 2023-03-16 | -$8.79K derived: sum of 3 quarters · filed 2023-03-16 | -$155.31K 10-K · filed 2023-03-16 |
| 2021-09-30 | $26.42K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $30.77K derived: sum of 2 quarters · filed 2022-11-10 | -$115.75K 10-Q · filed 2022-11-10 | -$551.55K derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $4.34K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | -$142.17K 10-Q · filed 2022-08-11 | -$577.97K derived: sum of 3 quarters · filed 2022-08-11 | |
| 2021-03-31 | -$146.52K 10-Q · filed 2022-05-12 | -$582.31K derived: sum of 2 quarters · filed 2022-05-12 | ||
| 2020-12-31 | -$435.80K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24 | $303.98K 10-K · filed 2022-03-24 | ||
| 2020-09-30 | $739.78K 10-Q · filed 2021-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| ALLURION TECHNOLOGIES, INC. (ALUR) | United States | $0.010B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |